Report me for selling fake medicine? Why are you crying when your illness relapses?

"Ms. Anna,"

"I'd like to ask if Novartis has decided to acquire Mr. Chen's special medicine formula."

"Isn't your company worried that this formula will be leaked? Or that other pharmaceutical companies will copy it in advance?"

A handsome male reporter asked the question.

They had also interviewed Chen Xuan about this issue before.

Now the interview subject has just shifted to Anna.

The former naturally does not have to consider the risks. Since the formula has already been sold, he can just sit back and collect the money.

But the latter is different. Once it is imitated by other pharmaceutical companies in advance, all the investment will be in vain.

It takes time, effort, and money... and in the end, you get nothing.

"About this question."

"We have assessed the risks before the acquisition."

"Our ultimate result is that this formula cannot be copied by other pharmaceuticals."

Anna said confidently, "At least at Novartis, we are confident that we can bring the drug to market before it is copied."

Her answer surprised everyone.

In this situation, what basis does Novartis have to make such an assessment?

Are they really not worried about being imitated by other pharmaceutical companies?

Or is there anything else you can rely on?

"Ms. Anna, you just said you weren't worried about other pharmaceutical companies copying your product."

"But as far as we know, Dasheng Pharmaceutical Group is conducting clinical trials, and if nothing unexpected happens, their new drug is almost identical to the formula in Mr. Chen Xuan's hands."

"If Dasheng Pharmaceutical Group's clinical trials are successful, then wouldn't your acquisition of the formula at this time become worthless?"

A reporter asked cryptically.

His meaning is also obvious.

That is, Dasheng Pharmaceutical Group has imitated Chen Xuan’s special medicine.

And clinical trials have been launched.

Of course, he didn't dare say such words openly.

After all, as a journalist, there are some things you say that could lead to legal action.

"We have never worried about this issue."

"In fact, we have also evaluated Dasheng Pharmaceutical Group's special medicine."

"The overall composition is indeed the same, but there are still subtle differences, and the differences are very small."

"But sometimes, a small difference can lead to completely different results." Anna said bluntly.

"As for the efficacy of the medicine,"

“Or in terms of patient indications.”

"Whether it will cause complications or medication safety issues is hard to say."

Her answer was very similar to Chen Xuan's.

But the difference is that the former's answer was very tactful, just saying that there is such a possibility.

The latter is more direct, stating the hidden dangers of the drug in an affirmative tone.

The tone and wording are different, but the meaning expressed is roughly the same.

"Damn, Anna actually thinks so too."

"Is there really a problem with Dasheng Pharmaceutical Group's new drug?"

"Can't Dasheng Pharmaceutical Group analyze all the ingredients in this drug? Aren't they impatiently launching clinical trials before a complete analysis?"

"Novartis is a world-class pharmaceutical giant, so their words are highly credible!"

"Chen Xuan said this before, and now Anna says it again. Will this happen..."

"Shit, Chen Xuan said before that this medicine can be fatal. I hope it doesn't really..."

Anna's answer shocked everyone.

Before, only Chen Xuan said this.

They are still skeptical, or simply question it directly.

Some even thought that he was so angry that he spoke without thinking.

But when Anna said the same thing,

Everyone had to start analyzing how big this possibility was.

After all, a pharmaceutical group of Novartis's level would not speak carelessly unless it was certain.

If it is proven that you told a lie in the future, the consequences will be very bad.

The key is,

If Novartis really suspects that there is a problem with Dasheng Pharmaceutical Group's new drug.